Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel in Advanced Esophageal Cancer
NCT00003326Phase 2Unknown
- Sponsor
- Theradex Oncology
- Start
- Sep 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in esophageal cancer, sponsored by Theradex Oncology. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00003326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003326.